
Eric K. Nicholson
Examiner (ID: 1800)
| Most Active Art Unit | 3501 |
| Art Unit(s) | 3508, 3642, 2899, 3744, 3501, 3627, 3629, 3626, PQT, 3679 |
| Total Applications | 2110 |
| Issued Applications | 1732 |
| Pending Applications | 114 |
| Abandoned Applications | 263 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4860268
[patent_doc_number] => 20080269118
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-30
[patent_title] => 'Use of Gpr100 receptor in diabetes and obesity regulation'
[patent_app_type] => utility
[patent_app_number] => 11/643408
[patent_app_country] => US
[patent_app_date] => 2006-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 31829
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20080269118.pdf
[firstpage_image] =>[orig_patent_app_number] => 11643408
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/643408 | Use of Gpr100 receptor in diabetes and obesity regulation | Dec 20, 2006 | Abandoned |
Array
(
[id] => 5258720
[patent_doc_number] => 20070212352
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-13
[patent_title] => 'Methods and compositions for the treatment of polycystic diseases'
[patent_app_type] => utility
[patent_app_number] => 11/643077
[patent_app_country] => US
[patent_app_date] => 2006-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 22603
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0212/20070212352.pdf
[firstpage_image] =>[orig_patent_app_number] => 11643077
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/643077 | Methods and compositions for the treatment of polycystic diseases | Dec 20, 2006 | Abandoned |
Array
(
[id] => 4909640
[patent_doc_number] => 20080020406
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-24
[patent_title] => 'Antibodies to a human Kchannel and therapeutic applications thereof'
[patent_app_type] => utility
[patent_app_number] => 11/633085
[patent_app_country] => US
[patent_app_date] => 2006-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 15959
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20080020406.pdf
[firstpage_image] =>[orig_patent_app_number] => 11633085
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/633085 | Antibodies to a human Kchannel and therapeutic applications thereof | Nov 29, 2006 | Abandoned |
Array
(
[id] => 5062488
[patent_doc_number] => 20070224127
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-27
[patent_title] => 'Human G protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure'
[patent_app_type] => utility
[patent_app_number] => 11/604179
[patent_app_country] => US
[patent_app_date] => 2006-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 38003
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20070224127.pdf
[firstpage_image] =>[orig_patent_app_number] => 11604179
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/604179 | Human G protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure | Nov 21, 2006 | Abandoned |
Array
(
[id] => 5091624
[patent_doc_number] => 20070231263
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-04
[patent_title] => 'Human G protein-coupled receptor and modulators thereof for the treatment of hyperglycemia and related disorders'
[patent_app_type] => utility
[patent_app_number] => 11/604178
[patent_app_country] => US
[patent_app_date] => 2006-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 62013
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0231/20070231263.pdf
[firstpage_image] =>[orig_patent_app_number] => 11604178
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/604178 | Human G protein-coupled receptor and modulators thereof for the treatment of hyperglycemia and related disorders | Nov 21, 2006 | Abandoned |
Array
(
[id] => 7691514
[patent_doc_number] => 20070232519
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-04
[patent_title] => 'Human G protein-coupled receptor and modulators thereof for the treatment of cardiovascualr disorders'
[patent_app_type] => utility
[patent_app_number] => 11/604187
[patent_app_country] => US
[patent_app_date] => 2006-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 63730
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20070232519.pdf
[firstpage_image] =>[orig_patent_app_number] => 11604187
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/604187 | Human G protein-coupled receptor and modulators thereof for the treatment of cardiovascualr disorders | Nov 21, 2006 | Abandoned |
Array
(
[id] => 5137763
[patent_doc_number] => 20070079392
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-05
[patent_title] => 'Human G protein-coupled receptors and modulators thereof for the treatment of metabolic-related disorders'
[patent_app_type] => utility
[patent_app_number] => 11/603625
[patent_app_country] => US
[patent_app_date] => 2006-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 40
[patent_no_of_words] => 99844
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0079/20070079392.pdf
[firstpage_image] =>[orig_patent_app_number] => 11603625
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/603625 | Human G protein-coupled receptors and modulators thereof for the treatment of metabolic-related disorders | Nov 21, 2006 | Abandoned |
Array
(
[id] => 5125487
[patent_doc_number] => 20070237758
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-11
[patent_title] => 'IMMUNOGLOBULIN FUSION PROTEIN FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 11/562299
[patent_app_country] => US
[patent_app_date] => 2006-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9357
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0237/20070237758.pdf
[firstpage_image] =>[orig_patent_app_number] => 11562299
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/562299 | IMMUNOGLOBULIN FUSION PROTEIN FORMULATIONS | Nov 20, 2006 | Abandoned |
Array
(
[id] => 5171816
[patent_doc_number] => 20070072248
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-29
[patent_title] => 'Constitutively activated human G protein coupled receptors'
[patent_app_type] => utility
[patent_app_number] => 11/603356
[patent_app_country] => US
[patent_app_date] => 2006-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 18480
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0072/20070072248.pdf
[firstpage_image] =>[orig_patent_app_number] => 11603356
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/603356 | Constitutively activated human G protein coupled receptors | Nov 20, 2006 | Abandoned |
Array
(
[id] => 5253308
[patent_doc_number] => 20070134764
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-14
[patent_title] => 'Endogenous and non-endogenous version of human G protein-coupled receptors'
[patent_app_type] => utility
[patent_app_number] => 11/601928
[patent_app_country] => US
[patent_app_date] => 2006-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 17603
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20070134764.pdf
[firstpage_image] =>[orig_patent_app_number] => 11601928
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/601928 | Endogenous and non-endogenous version of human G protein-coupled receptors | Nov 19, 2006 | Abandoned |
Array
(
[id] => 5285400
[patent_doc_number] => 20090099075
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-16
[patent_title] => 'Chimeric Keratin-Binding Effector Proteins'
[patent_app_type] => utility
[patent_app_number] => 12/094889
[patent_app_country] => US
[patent_app_date] => 2006-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 93290
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20090099075.pdf
[firstpage_image] =>[orig_patent_app_number] => 12094889
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/094889 | Chimeric Keratin-Binding Effector Proteins | Nov 14, 2006 | Abandoned |
Array
(
[id] => 21982
[patent_doc_number] => 07799543
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-09-21
[patent_title] => 'Human tumor necrosis factor receptor polynucleotides'
[patent_app_type] => utility
[patent_app_number] => 11/559332
[patent_app_country] => US
[patent_app_date] => 2006-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 55048
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/799/07799543.pdf
[firstpage_image] =>[orig_patent_app_number] => 11559332
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/559332 | Human tumor necrosis factor receptor polynucleotides | Nov 12, 2006 | Issued |
Array
(
[id] => 5107927
[patent_doc_number] => 20070066805
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-22
[patent_title] => 'HUMAN TUMOR NECROSIS FACTOR RECEPTOR'
[patent_app_type] => utility
[patent_app_number] => 11/559281
[patent_app_country] => US
[patent_app_date] => 2006-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 55065
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0066/20070066805.pdf
[firstpage_image] =>[orig_patent_app_number] => 11559281
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/559281 | HUMAN TUMOR NECROSIS FACTOR RECEPTOR | Nov 12, 2006 | Abandoned |
Array
(
[id] => 5057820
[patent_doc_number] => 20070060742
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-15
[patent_title] => 'ANTIBODIES TO HUMAN TUMOR NECROSIS FACTOR RECEPTOR'
[patent_app_type] => utility
[patent_app_number] => 11/559336
[patent_app_country] => US
[patent_app_date] => 2006-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 55064
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0060/20070060742.pdf
[firstpage_image] =>[orig_patent_app_number] => 11559336
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/559336 | ANTIBODIES TO HUMAN TUMOR NECROSIS FACTOR RECEPTOR | Nov 12, 2006 | Abandoned |
Array
(
[id] => 5172608
[patent_doc_number] => 20070073041
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-29
[patent_title] => 'HUMAN TUMOR NECROSIS FACTOR RECEPTOR POLYPEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 11/559290
[patent_app_country] => US
[patent_app_date] => 2006-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 55066
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0073/20070073041.pdf
[firstpage_image] =>[orig_patent_app_number] => 11559290
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/559290 | HUMAN TUMOR NECROSIS FACTOR RECEPTOR POLYPEPTIDES | Nov 12, 2006 | Abandoned |
Array
(
[id] => 102630
[patent_doc_number] => 07723299
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-05-25
[patent_title] => 'Methods for treating rheumatoid arthritis using a CTLA-4 fusion protein'
[patent_app_type] => utility
[patent_app_number] => 11/592227
[patent_app_country] => US
[patent_app_date] => 2006-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 13542
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/723/07723299.pdf
[firstpage_image] =>[orig_patent_app_number] => 11592227
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/592227 | Methods for treating rheumatoid arthritis using a CTLA-4 fusion protein | Nov 2, 2006 | Issued |
Array
(
[id] => 23194
[patent_doc_number] => 07794927
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-09-14
[patent_title] => 'Method for identifying agonists or antagonists of the G-protein coupled receptor mas-like 1'
[patent_app_type] => utility
[patent_app_number] => 11/556216
[patent_app_country] => US
[patent_app_date] => 2006-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5814
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 162
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/794/07794927.pdf
[firstpage_image] =>[orig_patent_app_number] => 11556216
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/556216 | Method for identifying agonists or antagonists of the G-protein coupled receptor mas-like 1 | Nov 2, 2006 | Issued |
Array
(
[id] => 4970750
[patent_doc_number] => 20070110752
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-17
[patent_title] => 'Fibroblast growth factor receptors and methods for their use'
[patent_app_type] => utility
[patent_app_number] => 11/591993
[patent_app_country] => US
[patent_app_date] => 2006-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 48
[patent_no_of_words] => 33436
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20070110752.pdf
[firstpage_image] =>[orig_patent_app_number] => 11591993
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/591993 | Fibroblast growth factor receptors and methods for their use | Oct 31, 2006 | Abandoned |
Array
(
[id] => 13240
[patent_doc_number] => 07807409
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-10-05
[patent_title] => 'Method for the recombinant expression of a polypeptide'
[patent_app_type] => utility
[patent_app_number] => 11/583573
[patent_app_country] => US
[patent_app_date] => 2006-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 12709
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/807/07807409.pdf
[firstpage_image] =>[orig_patent_app_number] => 11583573
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/583573 | Method for the recombinant expression of a polypeptide | Oct 18, 2006 | Issued |
Array
(
[id] => 5183508
[patent_doc_number] => 20070054862
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-08
[patent_title] => 'Methods of Identifying Compounds that Modulate IL-4 Receptor-Mediated IgE Synthesis Utilizing an Adenosine Kinase'
[patent_app_type] => utility
[patent_app_number] => 11/550731
[patent_app_country] => US
[patent_app_date] => 2006-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 30169
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20070054862.pdf
[firstpage_image] =>[orig_patent_app_number] => 11550731
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/550731 | Methods of Identifying Compounds that Modulate IL-4 Receptor-Mediated IgE Synthesis Utilizing an Adenosine Kinase | Oct 17, 2006 | Abandoned |